Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irofulven in Advanced Renal Cell Carcinoma
NCT00003390Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jun 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irofulven in renal cell carcinoma (RCC), sponsored by Memorial Sloan Kettering Cancer Center. Started Jun 1998; status: completed.
02
Drugs
irofulven
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00003390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003390.